We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From May 2019 to May 2024
By Margit Feher
BUDAPEST--Hungarian oil and gas company MOL Nyrt.'s (MOL.BU) shareholders approved on Thursday to pay out 50 billion forints ($178.5 million) in dividends after the company's 2014 results.
All shareholders present unanimously approved the dividend payment.
That's down from a dividend payment of HUF60 billion after the firm's 2013 earnings.
MOL's consolidated net profit totaled HUF4.08 billion last year. Consolidated operating cash flow was HUF434.53 billion last year, down from 614.69 billion a year earlier.
MOL's strong financial position makes it possible to pay a dividend that could reach HUF500 a share, the company's Chief Executive Jozsef Molnar told shareholders.
"We are planning to provide in the future as well a predictable and possibly rising dividend," the executive added.
Write to Margit Feher at margit.feher@wsj.com; Twitter: @margitfeher
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
